FDA Adverse Event Injury Summary report: N

MENTOR SMOOTH ROUND HIGH PROFILE

MDR report key: 8783526 · Received July 12, 2019

Report

Report Number
1645337-2019-15234
Event Type
Injury
Date Received
July 12, 2019
Date of Event
June 20, 2019
Report Date
June 20, 2019
Manufacturer
MENTOR TEXAS
Product Code
FWM
UDI-DI
00081317001669
PMA / PMN Number
P990075
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
VA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

ON (B)(6) 2019, DURING VISUAL EVALUATION A CREASE WAS OBSERVED IN THE POSTERIOR VIEW, LEAK TESTING REVEALED THERE WAS A TEAR WITHIN THE CREASE MEASURING APPROXIMATELY 0.2 CM. NO ADDITIONAL ANOMALIES WERE OBSERVED. A CREASE/FOLD FAILURE MAY BE THE RESULT OF THE CONTINUOUS AND SUSTAINED STRESSES TO THE DEVICE. A FOLD OR WRINKLE RUPTURE IS A KNOWN INHERENT RISK ASSOCIATED WITH THE USE OF MAMMARY PROSTHESES. AS STATED IN THE PRODUCT INSERT DATA SHEET, CREATING WRINKLES OR FOLDS SHOULD BE AVOIDED DURING IMPLANTATION OR OTHER PROCEDURES AS IT CAN RESULT IN RUPTURE IN A LATER TIME. ASYMMETRY OR ANISOMASTIA MAY BE ATTRIBUTED TO ONE OR MORE OF THE FOLLOWING: CONTRACTURE OF THE FIBROUS CAPSULE, SEROMA OR HEMATOMA, DEVELOPMENT OF POSTOPERATIVE BREAST DYSPLASIA, UNILATERAL DISCREPANCY IN MUSCLE DEVELOPMENT, DEFLATION OF THE IMPLANT, INCORRECT CHOICE OF IMPLANT SHAPE OR SIZE, AND SURGICAL TECHNIQUE. ASYMMETRY IS A KNOWN COMPLICATION ASSOCIATED WITH THESE DEVICES AND IS REFERENCED IN OUR CURRENT PRODUCT INSERT DATA SHEET. THE MANUFACTURING RECORDS WERE REVIEWED, AND THE MANUFACTURING CRITERIA WERE MET PRIOR TO THE RELEASE OF THIS LOT. DEFLATION, AS INDICATED IN THE PRODUCT INSERT DATA SHEET (PIDS), IS A KNOWN COMPLICATION ASSOCIATED WITH MENTOR MAMMARY PROSTHESES. IT SHOULD BE NOTED THAT AS PART OF OUR QUALITY PROCESS, EACH DEVICE IS VISUALLY INSPECTED DURING MANUFACTURING TO ENSURE THE DEVICE MEETS THE REQUIRED SPECIFICATIONS PRIOR TO SHIPMENT. COMPLAINT INFORMATION WILL BE INCLUDED IN COMPLAINT TRENDING THAT IS REVIEWED AND MONITOR BY QUALITY ASSURANCE ON A REGULAR BASIS TO DETERMINE IF FURTHER ACTION IS NECESSARY. MANUFACTURER¿S REFERENCE NUMBER: (B)(4).

Additional Manufacturer Narrative · 0

ON 7/30/2019, IT WAS REPORTED TO MENTOR THAT THE PATIENT EXPERIENCED PTOSIS ON THE LEFT BREAST IMPLANT. THE REPLACEMENT DEVICES WERE MENTOR SMOOTH ROUND MODERATE PROFILE 325CC ON THE LEFT AND MENTOR SMOOTH ROUND MODERATE PROFILE 350CC ON THE RIGHT. ON 8/2/2019, THE MENTOR FAILURE ANALYSIS LAB HAS RECEIVED THE DEVICE FOR EVALUATION. THE ANALYSIS HAS BEGUN BUT IS NOT COMPLETE AT THIS TIME. WHEN THE INVESTIGATIONAL ANALYSIS HAS BEEN COMPLETED, A SUPPLEMENTAL REPORT WILL BE SUBMITTED. MANUFACTURER¿S REFERENCE NUMBER: (B)(4).

Additional Manufacturer Narrative · 1

SINCE THE DEVICE HAS NOT BEEN RETURNED FOR ANALYSIS, NO PRODUCT FAILURE ANALYSIS CAN BE CONDUCTED, AND NO DETERMINATION OF POSSIBLE CONTRIBUTING FACTORS CAN BE MADE. AS SUCH, THE INVESTIGATION WILL BE CLOSED. IF THE COMPLAINT DEVICE IS RECEIVED IN THE FUTURE, THE INVESTIGATION WILL BE REOPENED AND CONDUCTED AS APPROPRIATE. A MANUFACTURING RECORD EVALUATION (MRE) WAS PERFORMED, AND NO ANOMALIES WERE FOUND RELATED TO THIS COMPLAINT. IN ADDITION, THE MRE VERIFIES THAT THE DEVICE WAS MANUFACTURED IN ACCORDANCE WITH DOCUMENTED SPECIFICATION AND PROCEDURES. REASON FOR DEVICE EXPLANT AND/OR REOPERATION: RUPTURE CONCOMITANT MEDICAL PRODUCTS: A MENTOR SMOOTH ROUND HIGH PROFILE 420CC , CATALOG 3503420, SERIAL NUMBER (B)(4), LOT 5942725. MANUFACTURER¿S REFERENCE NUMBER: (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT A (B)(6)-YEAR-OLD CAUCASIAN FEMALE PATIENT UNDERWENT PRIMARY BREAST AUGMENTATION WITH A MENTOR SMOOTH ROUND HIGH PROFILE 420CC BREAST IMPLANT THAT RUPTURED POSTOPERATIVELY. AS A RESULT, THE PATIENT WILL HAVE THE DEVICE EXPLANTED ON (B)(6) 2019.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
580339 MENTOR SMOOTH ROUND HIGH PROFILE PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE FWM MENTOR TEXAS 5942725 00081317001669

Patients

Seq Age Sex Outcome Treatment
1 34 YR Required Intervention